Industry Expert Previously Served as Risk Management Development and Scientific Lead at the European Medicines Agency (EMA)
RESEARCH TRIANGLE PARK, N.C. - Friday, March 28th 2014 [ME NewsWire]
(BUSINESS WIRE) Quintiles today announced that Stella Blackburn, M.B. B.S., has been appointed as the vice president and global head of Risk Management for its Real-World & Late Phase Research group. In this role, Dr. Blackburn will be responsible for leading the group’s risk management efforts in North America, EU and Asia-Pacific. Dr. Blackburn also will develop multidisciplinary benefit risk management services, review and assist customers with interpretation of pharmacovigilance legislation, and ensure compliance with regulations and best practices in the conduct of pharmacovigilance and risk management activities for the company’s real-world and late phase research efforts.
With more than two decades of experience in the pharmacovigilance and pharma
Read more »